Pamine Side Effects

Generic name: methscopolamine

Medically reviewed by Drugs.com. Last updated on Oct 25, 2023.

Note: This document provides detailed information about Pamine.

Applies to methscopolamine: oral tablets Side Effects associated with methscopolamine. Some dosage forms listed on this page may not apply specifically to the brand name Pamine.

Applies to methscopolamine: oral tablets.

Side effects include:

Xerostomia, decreased sweating, adverse ocular effects (e.g., blurred vision, mydriasis, cycloplegia, increased ocular tension).

For healthcare professionals

Applies to methscopolamine: oral tablet.

Cardiovascular

• Frequency not reported: Tachycardia, palpitation^[Ref]

Hypersensitivity

• Frequency not reported: Severe allergic reaction or drug idiosyncrasies including anaphylaxis^[Ref]

Nervous system

• Frequency not reported: Headaches, drowsiness, dizziness, loss of taste^[Ref]

Ocular

• Frequency not reported: Blurred vision, dilatation of the pupil, cycloplegia, increased ocular tension^[Ref]

Gastrointestinal

• Frequency not reported: Nausea, vomiting, constipation, bloated feeling, xerostomia^[Ref]

Dermatologic

• Frequency not reported: Decreased sweating, urticaria and other dermal manifestations^[Ref]

Genitourinary

• Frequency not reported: Urinary hesitancy and retention, impotence, suppression of lactation^[Ref]

Other

• Frequency not reported: Weakness^[Ref]

Psychiatric

• Frequency not reported: Nervousness, mental confusion, insomnia^[Ref]

Further information

Pamine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer